Finance

Arcus Biosciences: A High-Risk Speculation With Multiple Large, Near-Term Catalysts

Apr 2, 2025 - 21:58
 0
Read More

Tags:

Previous Article

The Sound Of Silence: What Powell And The Fed Aren't Saying

Next Article

GSK: Under Threat From 'Double Whammy' Of Vaccine Skepticism And Pharma Tariffs

Related Posts

Meta Platforms, Inc. (META): Among Billionaire Ken Fisher’s Top Growth Stock Picks

Meta Platforms, Inc. (META): Among Billionaire Ken Fish...

Apr 2, 2025  0

U.K. Regulator Bans Crispin Odey From Finance Industry

U.K. Regulator Bans Crispin Odey From Finance Industry

Mar 18, 2025  0

US government could face default risk as soon as July, analyst projects

US government could face default risk as soon as July, ...

Mar 26, 2025  0